The Cancer Vaccine Institute at UW Medicine in Seattle, Wash., is a collaboration of scientists, doctors, nurses, patients and philanthropists, all determined to eliminate cancer. Our mission is to diagnose, prevent and treat this disease by developing immune system-based approaches, ones that bring the power of precision medicine and cancer immunology out of the lab and into the lives of people with cancer or at high risk for cancer.
We are especially focused on developing vaccines to prevent cancers responsible for millions of deaths and enormous healthcare costs — breast, colon, ovarian, prostate, pancreatic and lung cancers — and to prevent cancer relapse. Cancer vaccines are ideally suited to both primary and secondary cancer prevention.
Mary L. (Nora) Disis, M.D.
Director, UW Medicine Cancer Vaccine Institute
Athena Distinguished Professor of Breast Cancer Research
Dr. Disis was educated at the University of Nebraska Medical School, the University of Illinois College of Medicine and UW Medicine-Fred Hutchinson Cancer Research Center. She was one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen, and she holds several patents in the field of targeted cancer therapy and cancer diagnostics. In addition, she serves as the inaugural editor-in-chief of JAMA Oncology. Read more about Dr. Disis.